TDR history: making a difference for over three decades

"TDR uses the tools of scientific investigation to understand why good drugs, good diagnostic tests, and good preventive strategies fail to reach people in need. In other words, to find the barriers to access, including costs, in impoverished settings and break them down.”

Dr Margaret Chan
Director-General, the World Health Organization

TDR’s rich legacy began with the agreement at the World Health Assembly in 1974 to set up the programme. During 2014, we are celebrating this milestone at several events throughout the year. On 24 June, the annual Joint Coordinating Board honours the foundation with speeches by 2 former TDR Directors.

Find out more about TDR’s rich history

TDR has provided research evidence to five major elimination campaigns for neglected diseases and we've been part of the development of 12 new drugs. We’ve also helped to establish the effectiveness of insecticide-treated bednets and artemisinin combination therapy, now the mainstay of malaria control and treatment. Importantly, we've identified social and gender barriers that impede access to treatment and care, and provided evidence of the strength of communities in extending the health systems, starting with river blindness annual treatments, going on to diagnose and treat malaria, and to prevent dengue and Chagas disease transmission.

We've also trained thousands of researchers: in just about every low- and middle-income country, many of the scientific leaders and policy-makers are former TDR grantees.

Sign up for TDR news updates!

Video about TDR